Welcome to our dedicated page for BlackRock SEC filings (Ticker: BLK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on BlackRock's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into BlackRock's regulatory disclosures and financial reporting.
Gordon M. Nixon, a director of BlackRock, Inc. (BLK), was granted 31 shares of common stock on 09/30/2025 under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan. The grant was valued using the closing price of $1,165.87 per share on that date and was recorded at a price of $0 for the reporting transaction (a director award). After the grant, Mr. Nixon beneficially owned 5,275 shares. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Amin H. Nasser, a director of BlackRock, Inc. (BLK), was granted 817 shares of Common Stock on 09/30/2025 under the company's stock award plan for nonemployee directors. The grant was reported as a non‑derivative acquisition with a reported price of $0 (a stock award), valued using the closing share price of $1,165.87 on the grant date. The form shows 142 shares beneficially owned following the transaction as held indirectly via a Family Trust. The Form 4 was signed by an attorney‑in‑fact on 10/02/2025 and records standard director equity compensation rather than an open‑market purchase.
Freda Fabrizio, a director of BlackRock, Inc. (BLK), was granted 3,530 shares of common stock on 09/30/2025 under the company's Third Amended and Restated 1999 Stock Award and Incentive Plan. The grant was recorded as a non‑derivative acquisition with a reported price of $0 because the shares were awarded, and the filing cites a closing stock price of $1,165.87 per share on the grant date to determine award value. Following the transaction, Ms. Fabrizio beneficially owns 3,530 shares. The Form 4 was signed by an attorney‑in‑fact on behalf of Ms. Fabrizio and reports the transaction as a routine director award rather than a purchased or sold position.
William E. Ford, a director of BlackRock, Inc. (BLK), was granted 31 shares of Common Stock on 09/30/2025 under the Third Amended and Restated BlackRock, Inc. 1999 Stock Award and Incentive Plan. The grant used the closing price of $1,165.87 per share on that date. Following the reported transaction, Mr. Ford beneficially owns 16,386 shares. The Form 4 was signed on behalf of Mr. Ford by an attorney-in-fact and filed with a signature date of 10/02/2025.
BlackRock, Inc. submitted a 13F combination report disclosing 49,987 reported positions with a total reported market value of $5,253,068,841,298 for the quarter ended 06-30-2025. The filing identifies 31 other included managers and lists multiple BlackRock operating subsidiaries that share reporting obligations. This document is a routine institutional holdings disclosure, not an operational or earnings filing.
BlackRock, Inc. (BLK) – Form 144 insider sale notice. A company insider plans to sell 17,142 shares of BLK common stock—about 0.01 % of the 154.9 million shares outstanding—through Merrill Lynch on or after 30 Jul 2025. At the filing-date market price, the stake is valued at roughly $19.2 million.
The shares were acquired the same day via the exercise of employee stock options; no prior sales have been reported in the past three months. The filer affirms no undisclosed material adverse information and acknowledges Rule 10b5-1 requirements.
While the dollar amount is sizable, the sale represents an immaterial fraction of the float and should not meaningfully affect BlackRock’s capital structure or trading liquidity. Investors typically monitor Form 144s as a gauge of insider sentiment; however, the scale here suggests a routine, compensation-related disposal rather than a directional signal on fundamentals.
On 25 Jul 2025, BlackRock (BLK) Senior Managing Director Rachel Lord filed a Form 4 disclosing a cashless exercise and sale of employee stock options. She exercised 18,036 options at a strike price of $513.50 (Code M) and immediately sold the same number of common shares in seven open-market transactions (Code S) at weighted-average prices ranging from $1,123.35 to $1,129.61. Gross sale value is roughly $20 million, while no derivative securities remain outstanding from the grant that fully vested between 2022-2024.
Following the transactions, Lord’s direct beneficial ownership fell from 37,241 to 19,205 shares, a reduction of 18,036 shares (≈0.01 % of BLK shares outstanding). The remaining holding includes restricted stock units that will vest over the next one to three years. No Rule 10b5-1 trading plan or purchase activity was disclosed.